[EWTX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[EWTX] Edgewise Therapeutics, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -19.77%
YoY- -53.66%
Quarter Report
EWTX's Result
EWTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 2,252 0 0 0 0 -
PBT -31,497 -28,525 -30,143 -25,713 -21,469 -22,838 -19,415 38.10%
Tax 0 482 3,604 -497 339 -3,107 -2,664 -
NP -31,497 -28,525 -30,143 -25,713 -21,469 -19,731 -16,751 52.40%
Tax Rate - - - - - - - -
Total Cost 31,497 28,525 32,395 25,713 21,469 19,731 16,751 52.40%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -1,338.50 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.34 -0.33 -0.47 -0.41 -0.34 -0.31 -0.26 19.60%
EPS Diluted -0.34 -0.33 -0.47 -0.41 -0.34 -0.31 -0.26 19.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.